Microglial efferocytosis: Diving into the Alzheimer's Disease gene pool
Neuroimmunology, Genetics, Genomics and seminar by Carmen Romero-Molina & Francesca Garretti, Drs., Icahn School of Medicine at Mount Sinai
Hosted by Open Box Science
Tuesday 01:00–02:10 New York (GMT-5)
Recording available
Abstract
Genome-wide association studies and functional genomics studies have linked specific cell types, genes, and pathways to Alzheimer’s disease (AD) risk. In particular, AD risk alleles primarily affect the abundance or structure, and thus the activity, of genes expressed in macrophages, strongly implicating microglia (the brain-resident macrophages) in the etiology of AD. These genes converge on pathways (endocytosis/phagocytosis, cholesterol metabolism, and immune response) with critical roles in core macrophage functions such as efferocytosis. Here, we review these pathways, highlighting relevant genes identified in the latest AD genetics and genomics studies, and describe how they may contribute to AD pathogenesis. Investigating the functional impact of AD-associated variants and genes in microglia is essential for elucidating disease risk mechanisms and developing effective therapeutic approaches." https://doi.org/10.1016/j.neuron.2022.10.015
Topics
Related seminars
- Video · 1 h 10 min · Oct 8, 2020Beth Stevens, Harvard Medical School
Human TREM2 knockout microglia fail to activate towards Alzheimer’s disease pathology
Video · Dec 16, 2020Amanda McQuade, UC Irvine
More from Open Box Science
All talksIL1beta+ macrophages fuel pathogenic inflammation in pancreatic cancer
Dec 12, 2023Nicoletta CaronniCircadian modulation by time-restricted feeding rescues brain pathology and improves memory in mouse models of Alzheimer’s disease
Video page · Nov 9, 2023Daniel S. WhittakerIrisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling
Video page · Nov 9, 2023Eunhee Kim